These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36451388)

  • 21. Incidence of Restenosis Following Rapamycin or Paclitaxeleluting Stent in Coronary Stent Implantation.
    Shakarami A
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(3):196-201. PubMed ID: 34886782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T; Sun JL; Zhang J
    Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors of in-stent restenosis in patients with diabetes mellitus after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
    Li S; Luo C; Chen H
    Medicine (Baltimore); 2021 Apr; 100(15):e25484. PubMed ID: 33847656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
    Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
    Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence and predictive factors of restenosis in coronary heart disease patients underwent sirolimus-eluting stent implantation.
    Zhao J; Wang X; Wang H; Zhao Y; Fu X
    Ir J Med Sci; 2020 Aug; 189(3):907-915. PubMed ID: 31989420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of anemia on in-stent restenosis after percutaneous coronary intervention.
    Hu H; Wang S; Tang G; Zhai C; Shen L
    BMC Cardiovasc Disord; 2021 Nov; 21(1):548. PubMed ID: 34798833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of plasma Rap1A levels in patients with in-stent restenosis after percutaneous coronary intervention and the underlying mechanisms.
    Gao H; Kuang Y; Liu Y; Zhang Y; Wang P; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1650-1658. PubMed ID: 38432855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The frequency and clinical characteristics of in-stent restenosis due to calcified nodule development after coronary stent implantation.
    Isodono K; Fujii K; Fujimoto T; Kasahara T; Ariyoshi M; Irie D; Tsubakimoto Y; Sakatani T; Matsuo A; Inoue K; Fujita H
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):15-23. PubMed ID: 32734495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.
    He W; Xu C; Wang X; Lei J; Qiu Q; Hu Y; Luo D
    BMC Cardiovasc Disord; 2021 Sep; 21(1):435. PubMed ID: 34521385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictor of in-stent restenosis in patients with drug-eluting stent (PRIDE)- a retrospective cohort study.
    Gupta PK; Balachander J
    Clin Investig Arterioscler; 2021; 33(4):184-194. PubMed ID: 33622608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistant in-stent restenosis in the drug eluting stent era.
    Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors associated with intra-stent restenosis after percutaneous coronary intervention.
    Alexandrescu DM; Mitu O; Costache II; Macovei L; Mitu I; Alexandrescu A; Georgescu CA
    Exp Ther Med; 2021 Oct; 22(4):1141. PubMed ID: 34504587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Osama S; Wirth F; Zahra G; Barbara C; Xuereb RG; Camilleri L; Azzopardi LM
    Drug Metab Pers Ther; 2021 Jan; 37(2):155-161. PubMed ID: 34851561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
    Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary CT angiography (CCTA) using third-generation dual-source CT for ruling out in-stent restenosis.
    Eckert J; Renczes-Janetzko P; Schmidt M; Magedanz A; Voigtländer T; Schmermund A
    Clin Res Cardiol; 2019 Apr; 108(4):402-410. PubMed ID: 30187179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Nutritional Index as a Novel Predictor of In-Stent Restenosis: A Retrospective Study.
    Balun A; Akgümüş A; Özbek K; Güven Çetin Z
    Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109621
    [No Abstract]   [Full Text] [Related]  

  • 38. The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro.
    Kastl SP; Katsaros KM; Krychtiuk KA; Jägersberger G; Kaun C; Huber K; Wojta J; Speidl WS
    PLoS One; 2020; 15(5):e0232483. PubMed ID: 32392256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare-Metal Stent.
    Celik IE; Yarlioglues M; Kurtul A; Duran M; Koseoglu C; Oksuz F; Aksoy O; Murat SN
    Angiology; 2016 May; 67(5):478-83. PubMed ID: 26243483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.
    Joo HJ; Jeong HS; Kook H; Lee SH; Park JH; Hong SJ; Yu CW; Lim DS
    BMC Cardiovasc Disord; 2018 Jun; 18(1):114. PubMed ID: 29890945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.